Fri, January 7, 2022
Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021
Thu, December 30, 2021
Wed, December 29, 2021
Tue, December 28, 2021
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021

Elemer Piros Upgraded (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-40-on-jan-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Elemer Piros of Roth Capital, Upgraded "Unity Biotechnology, Inc." (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022.

Elemer has made no other calls on UBX in the last 4 months.



There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Elemer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Elemer


  • Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Wednesday, November 10th, 2021

Publication Contributing Sources